Preclinical toxicity evaluation of JD5037, a peripherally restricted CB<sub>1</sub> receptor inverse agonist, in rats and dogs for treatment of nonalcoholic steatohepatitis.
- DOI
- 10.1016/j.yrtph.2019.104483
- Published
- 2019-09-30
- Container
- Regul Toxicol Pharmacol
- Publisher
- Not recorded
- Open access
- no
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.yrtph.2019.104483,
title = {Preclinical toxicity evaluation of JD5037, a peripherally restricted CB\<sub\>1\</sub\> receptor inverse agonist, in rats and dogs for treatment of nonalcoholic steatohepatitis.},
author = {Kale VP and Gibbs S and Taylor JA and Zmarowski A and Novak J and Patton K and Sparrow B and Gorospe J and Anand S and Cinar R and Kunos G and Chorvat RJ and Terse PS.},
year = {2019},
journal = {Regul Toxicol Pharmacol},
doi = {10.1016/j.yrtph.2019.104483},
url = {https://doi.org/10.1016/j.yrtph.2019.104483}
}RIS
TY - JOUR TI - Preclinical toxicity evaluation of JD5037, a peripherally restricted CB<sub>1</sub> receptor inverse agonist, in rats and dogs for treatment of nonalcoholic steatohepatitis. AU - Kale VP AU - Gibbs S AU - Taylor JA AU - Zmarowski A AU - Novak J AU - Patton K AU - Sparrow B AU - Gorospe J AU - Anand S AU - Cinar R AU - Kunos G AU - Chorvat RJ AU - Terse PS. PY - 2019 JO - Regul Toxicol Pharmacol DO - 10.1016/j.yrtph.2019.104483 UR - https://doi.org/10.1016/j.yrtph.2019.104483 ER -
APA
VP, K., S, G., JA, T., A, Z., J, N., K, P., B, S., J, G., S, A., R, C., G, K., RJ, C., & PS., T. (2019). Preclinical toxicity evaluation of JD5037, a peripherally restricted CB<sub>1</sub> receptor inverse agonist, in rats and dogs for treatment of nonalcoholic steatohepatitis.. Regul Toxicol Pharmacol. https://doi.org/10.1016/j.yrtph.2019.104483
Source records
- europe-pmc · retrieved 2026-09-27T04:26:27.347Z